Offshore drillers like Transocean (RIG), Seadrill (SDRL) and Noble (NE) have gotten pounded this year. Is it time to buy? Well, if not that, at least its time to become less bearish, say the folks at BMO Capital Markets, who upgraded the shares of Transocean, Seadrill, Diamond Offshore (DO), Ensco (ESV), Noble, Rowan (RDC) and Atwood Oceanics (ATW).
BloombergBMO Capital Markets’ Alan Laws and Peyton Mason explain why they see better times ahead of offshore-drilling stocks:
We are upgrading the offshore drillers to Market Perform from Underperform given what we view as a better risk/reward balance over next 6 to 12 months. We believe the stocks largely discount the weakness seen/expected in the industry in 2014/2015 with consensus estimates now reflecting the anticipated level of day rate reductions. Recent fixtures, while likely negotiated in 2013, suggest activity is resuming (albeit slowly), and we expect this to increase as ��learing house��rates are reached for producer cost containment. In other words, the potential for a surprise demand uptick now outweighs already price- in risks of further weakening, in our view. In our view, the largest risk to our upgrade today is being a bit early given what could be a longer drawn-out return to activity. That said we want to be positioned for the technical inflection like the land rigs in fall 2012. Stock downside appears limited with an already negative bias in expectations and ultimately investor fatigue with the thesis. Fundamental valuation metrics (PE and P/BV) also suggest trough levels. We think differentiation (vs. being viewed as one group) is likely to become more pronounced in a bounce, and we prefer ATW and ESV over peers. While other subsectors in Oil Services remain more attractive today, we believe value and contrarian investors should start kicking tires.
10 Best Oil Service Stocks To Watch Right Now: Associated Banc-Corp(ASBC)
Associated Banc-Corp, a bank holding company, offers various banking and financial services to individuals and businesses primarily in Wisconsin, Illinois, and Minnesota. Its Banking segment provides loans and deposit products to businesses, governments, and consumers. Its products and services include checking, savings, money market deposit, and IRA accounts, as well as certificates of deposit and safe deposit boxes; and home equity loans and lines of credit, residential mortgage loans and mortgage refinancing, education loans, and personal and installment loans. This segment?s products and services also include business checking accounts, business loans, real estate financing, construction loans, letters of credit, revolving credit arrangements, business credit cards, equipment and machinery leases, night depository, cash management, international banking, check clearing, safekeeping, and other banking-based services. The company?s Wealth Management segment provides va rious fiduciary, investment management, advisory, and corporate agency services for individuals, corporations, small businesses, charitable trusts, endowments, foundations, and institutional investors. This segment also offers life, property, casualty, and credit and mortgage insurance, as well as fixed annuities and employee group benefits consulting and administration services; investment brokerage, variable annuities, and discount and online brokerage services; and trust/asset/investment management, administration of pension, profit-sharing and other employee benefit plans, personal trusts, and estate planning services. The company offers its products through branch facilities, loan production offices, supermarket branches, a customer service call center, an interstate automated teller machine network, and Internet banking services. As of December 31, 2010, its banking subsidiary had 280 offices in approximately 150 communities. The company was founded in 1964 and is base d in Green Bay, Wisconsin.
Advisors' Opinion:- [By Monica Gerson]
Associated Banc-Corp (NASDAQ: ASBC) shares rose 1.73% to reach a new 52-week high of $18.20 after the company announced a $120 million buyback plan and shelf registration of $500 million.
- [By John Maxfield]
Given that you clicked on this article, it seems safe to assume you either own stock in Associated Banc-Corp. (NASDAQ: ASBC ) or are considering buying shares in the near future. If so, then you've come to the right place. The table below reveals the nine most critical numbers that investors need to know about Associated Banc-Corp stock before deciding whether to buy, sell, or hold it.
Best Oil Service Companies To Invest In 2014: Culp Inc (CFI)
Culp, Inc., incorporated on March 16, 1972, manufactures, sources, and markets mattress fabrics used for covering mattresses, box springs, and foundations and upholstery fabrics primarily for use in production of upholstered furniture. The Company operates in two segments: mattress fabrics and upholstery fabrics. The mattress fabric business markets woven and knitted fabrics, and sewn covers made from those fabrics, which are used primarily in the production of bedding products, including mattresses, box springs, and foundations. The upholstery fabric business markets a variety of fabric products that are used in the production of upholstered furniture, such as, sofas, recliners, chairs, loveseats, sectionals, and sofa-beds. The Company markets a variety of fabrics in different categories to its global customer base, including fabrics produced at the Company's manufacturing facilities and fabrics produced by other suppliers.
The Company markets products primarily to manufacturers that operate in two principal markets. The mattress fabrics segment supplies the bedding industry, which produces mattress sets (mattresses, box springs, and foundations). The upholstery fabrics segment supplies the residential furniture industry. As of April 28, 2013, the Company had fourteen active manufacturing plants and distribution facilities, which are located in North and South Carolina; Quebec, Canada; Shanghai, China; and Poznan, Poland. The Company also sources fabrics from other manufacturers, located mostly in China and Turkey, with those fabrics being produced specifically for the Company and created by its designers. The Company operates distribution centers in North Carolina and Shanghai, China to facilitate distribution of its products, and a distribution facility in Poznan, Poland.
Mattress Fabrics
The Company�� mattress fabrics segment, also known as Culp Home Fashions, manufactures and markets mattress fabric to bedding manufacturers. These fabrics encompass woven! jacquard fabrics, knitted fabrics, and some converted fabrics. Culp Home Fashions has manufacturing facilities located in Stokesdale and High Point, North Carolina, and St. Jerome, Quebec, Canada. One Stokesdale plant and the St. Jerome plant both manufacture and finish jacquard (damask) fabric. Its products include woven jacquards, which include various patterns and intricate designs, Converted, which includes suedes, pile and embroidered fabrics, and Knitted Fabric, which includes various patterns and intricate designs produced on special-width circular knit machines utilizing a variety of synthetic and natural yarns.
Upholstery Fabrics
The Company�� upholstery fabrics segment markets fabrics for residential furniture, including synthetic leathers, velvets, woven jacquards, woven dobbies, and suedes. This segment operates fabric manufacturing facilities in Anderson, South Carolina, and Shanghai, China. The Company markets fabrics produced in these two locations, as well as a variety of upholstery fabrics sourced from third party producers, mostly in China. Its products include Synthetic Leathers, which includes composite products which are face finished with polyurethane, either by printing or coating, velvets, woven jacquards, and suedes.
The Company competes with Bekaert Textiles B.V., Global Textile Alliance, Richloom Fabrics, Merrimack Fabrics, Morgan Fabrics, and Specialty Textile, Inc.
Advisors' Opinion:- [By Monica Gerson]
Culp (NYSE: CFI) is estimated to post its Q1 earnings at $0.35 per share on revenue of $74.39 million.
Esterline Technologies (NYSE: ESL) is expected to post its Q3 earnings at $1.40 per share on revenue of $516.57 million.
Best Oil Service Companies To Invest In 2014: Pain Therapeutics Inc (PTIE)
Pain Therapeutics, Inc., incorporated in May 1998, is a biopharmaceutical company that develops drugs. The Company has four drug candidates in clinical programs, including REMOXY, abuse-resistant hydromorphone, abuse-resistant hydrocodone and a radio-labeled monoclonal antibody to treat metastatic melanoma. It is also working on a new treatment for patients with hemophilia. The Company�� lead drug candidate is REMOXY, which is a painkiller. It has collaboration agreement with King Pharmaceuticals, Inc. (King) develops and commercializes REMOXY and other opioid painkillers. The Company and King jointly managed a Phase III clinical program and New Drug Application (NDA) submission for REMOXY. It is also developing a pipeline of drug candidates in the area of oncology and hematology. It owns all commercial rights to its pipeline of drug candidates in oncology and hematology. As of December 31, 2010, the Company leased approximately 30,700 square feet of space in San Mateo, California and all of its operations are located in San Mateo.
REMOXY
REMOXY is a controlled-release oral capsule form of oxycodone in a highly viscous liquid formulation matrix that includes excipients. It is formulated to help address issues of abuse and misuse of time-release oxycodone tablets. REMOXY�� capsule dosage form provides therapeutic drug levels of oxycodone on a twice-daily dosing schedule, while resisting the rapid increases in plasma levels of oxycodone associated with common methods of abuse and misuse. Its formulation also resists delivery by unapproved routes of administration, such as injection, snorting or inhalation.
Metastatic Melanoma
The Company is developing a drug candidate called PTI-188 to treat metastatic melanoma, a form of skin cancer. PTI-188 is a monoclonal antibody linked to a radioisotope, intended to deliver doses of radiation lethal to melanoma tumors without harming normal tissue. In March 2010, the Company announced data from two open-label! , dose-escalating Phase I studies conducted in Israel to assess the safety, pharmacokinetics, dosimetry and anti-tumor activity of PTI-188. During the year ended December 31, 2010, the second study was completed. The technology used in this program was developed at the Albert Einstein College of Medicine (AECOM). It had licensed worldwide commercial rights to this technology from AECOM.
Hemophilia
The Company has a gene transfer program, initially developed at Stanford University, focused at correcting a genetic disorder in which patients are unable to stop bleeding. During 2010, it conducted a variety of pre-clinical studies with this technology. The Company has licensed worldwide commercial rights to the technology used in this program from Poetic Genetics, LLC (Poetic).
Other product candidates
The Company�� alliance with King includes development of three other abuse-resistant opioid product candidates: hydromorphone, hydrocodone and oxymorphone. Its abuse-resistant formulations of hydromorphone and hydrocodone have completed Phase I clinical trials. In January 2011, the Company announced that the Food and Drug Administration (FDA) had accepted its investigational IND, for abuse-resistant oxymorphone.
The Company competes with Roxane Laboratories, Purdue Pharma, King Pharmaceuticals, Inc., Abbott Laboratories, Cephalon, Endo Pharmaceuticals, Teva Pharmaceuticals, Elkins-Sinn, Watson Laboratories, Ortho-McNeil Pharmaceutical and Forest Pharmaceuticals.
Advisors' Opinion:- [By Sean Williams]
However, all isn't well when it comes to the future of abuse-resistant painkiller Remoxy, which was developed by Pain Therapeutics (NASDAQ: PTIE ) , using Durect's�special technology-based gel capsule to prevent abuse, and is licensed by Pfizer (NYSE: PFE ) . Remoxy has been rejected twice by the FDA -- the most recent coming in mid-2011 -- and Pfizer commented this morning that if it were to seek reapproval for the drug it wouldn't be for at least two more years. Given Pfizer's extensive product pipeline, losing Remoxy wouldn't be a big deal. For micro-cap clinical-stage companies like Pain Therapeutics and Durect, it'd be a gigantic blow. Fittingly, Pain Therapeutics and Durect shares imploded by 50% and 34%, respectively, on Friday.
- [By Jessica Alling]
Elsewhere, Pfizer is evaluating its continued partnership on an experimental oxycodone capsule, Remoxy. The drug is an extended-release formula that is targeted at reducing abuse of the painkiller. After years of setbacks and postponements for FDA approval, Pfizer is weighing its options. Its partners for the drug, Pain Therapeutics (NASDAQ: PTIE ) and Durect, have both fallen heavily due to the news, with Pain Therapeutics falling more than 50% -- its largest decline ever.
Best Oil Service Companies To Invest In 2014: Lazard LTD. (LAZ)
Lazard Ltd., together with its subsidiaries, operates as a financial advisory and asset management firm. The company�s Financial Advisory segment offers various advisory services on mergers and acquisitions, and other strategic matters, as well as on restructurings, capital structure, capital raising, and other financial matters. Its Asset Management segment provides investment solutions and investment management services in equity and fixed income strategies; and alternative investments and private equity funds. The company serves corporations, governments, institutions, partnerships, and individual clients. It operates from 42 cities across 27 countries in Europe, North America, Asia, Australia, the Middle East, and Central and South Americas. Lazard Ltd. was founded in 1848 and is based in Hamilton, Bermuda.
Advisors' Opinion:- [By Ben Levisohn]
Horowitz predicts Lazard (LAZ), which returned 55% last year, to gain just 4% in 2014 as weaker merger & acquisition activity will weight on earnings.
- [By EXPstocktrader]
1) Lazard (LAZ): Management meetings highlight under-appreciated earnings drivers; raising PT to $85; BUY
2) Bank of America/Merrill Lynch (BAC): Questcor Pharmaceuticals is upgraded from "neutral" to "buy." The target price has been raised from $58 to $80.
- [By Matt Koppenheffer and David Hanson]
An article in Financial Times came out suggesting that smaller investment banks, such as Greenhill (NYSE: GHL ) or Lazard (NYSE: LAZ ) , might be workplaces that offer more options and flexibility for those pursuing a banking career. Will we start to see the best talent move away from Wall Street's biggest banks to find the true opportunities? In the video, Matt tells us what effect this could have on big banking as a whole.
Best Oil Service Companies To Invest In 2014: New York Mortgage Trust Inc.(NYMT)
New York Mortgage Trust, Inc., together with its subsidiaries, operates as a real estate investment trust (REIT) in the United States. The company engages in acquiring, investing, financing, and managing mortgage-related assets. It primarily invests in agency residential adjustable-rate, hybrid adjustable-rate, and fixed-rate mortgage-backed securities (RMBS); non-Agency RMBS; prime adjustable-rate residential mortgage loans held in securitization trusts; commercial mortgage-backed securities; commercial mortgage loans; and other commercial real estate-related debt investments. The company has elected to be taxed as a REIT and will not be subject to federal income tax if it distributes at least 90% of its REIT taxable income to its stockholders. New York Mortgage Trust, Inc. was founded in 1989 and is headquartered in New York, New York.
Advisors' Opinion:- [By Lawrence Meyers]
Next Page
Preferred Stocks: New York Mortgage Trust (NYMT)Dividend Yield: 8.2%
New York Mortgage Trust (NYMT) is a mortgage real estate investment trust, or mREIT, that acquires, invests in, finances and manages mortgage related securities. These mREITs are very much tied to interest rates, so while rates are low, the stocks will do well. NYMT common stock, in fact, yields more than 14%. Yet that�� why I would choose the New York Mortgage Trust 7.75% Preferred Series B (NYMTP).
- [By Susan J. Aluise]
LEN stock is only up about 3% in 2014, but it’s clearly a growth play. With a price-to-earnings-growth (PEG) ratio of just 0.6 and a forward P/E of a little more than�12, LEN stock looks undervalued now. LEN pays a nominal dividend with a 0.4% current yield, but the company knows its market and is positioning its new properties well, so LEN promises to be a solid buy-and-hold stock.
REIT:�New York Mortgage�(NYMT)There are two basic types of REITs –�those that hold real property and those that hold mortgages on property (mortgage or mREITs). Among mREITs, New York Mortgage�(NYMT)�is a so-called ��ybrid mREIT�� meaning that it holds a combination of federally guaranteed (agency) and non-agency debt, like commercial mortgage-backed securities (CMBS).
- [By Eric Volkman]
Investors are being rewarded for putting their trust in New York Mortgage Trust (NASDAQ: NYMT ) . The REIT has declared a common stock dividend for its current quarter of $0.27 per share, to be paid on July 25 to shareholders of record as of June 28. That amount matches each of the company's preceding four distributions, the most recent of which was doled out at the end of April. Before that, it paid $0.25 per share.
- [By Amanda Alix]
More mREITs stay the course, but two trim payouts
Despite suffering many tumbles and bruises, several mREITs have announced that their dividends will be unchanged from the previous quarter. Several did so last week, and yesterday saw Hatteras Financial (NYSE: HTS ) , an agency-only trust, keeping its own $0.70 per share�payout the same. Hybrid New York Mortgage Trust (NASDAQ: NYMT ) also kept its dividend stable, at $0.27 per share, in line with its four most recent distributions.
Best Oil Service Companies To Invest In 2014: Peabody Energy Corporation(BTU)
Peabody Energy Corporation engages in the mining of coal. It mines, prepares, and sells thermal coal to electric utilities and metallurgical coal to industrial customers. The company owns interests in 30 coal mining operations located in the United States and Australia, as well as owns joint venture interest in a Venezuela mine. It is also involved in marketing, brokering, and trading coal. In addition, the company develops a mine-mouth coal-fueled generating plant; and Btu Conversion projects that are designed to convert coal to natural gas or transportation fuels; and clean coal technologies. As of December 31, 2011, it had 9 billion tons of proven and probable coal reserves. The company was founded in 1883 and is headquartered in St. Louis, Missouri.
Advisors' Opinion:- [By Victor Selva]
Finally, I always like to see one of the most important financial ratios applying to stockholders, the best measure of performance for a firm's management: the return on equity. With a ROE of 13.2%, it is well above the industry mean of 3.7% and competitors such as Alpha Natural Resources�Inc. (ANR), Arch Coal Inc. (ACI) and Peabody Energy Corp. (BTU).
- [By Rich Duprey]
Peabody Energy� (NYSE: BTU ) realizes 25% of its revenues from Asia (up from 18% the year before) while earlier this year�Consol Energy completed the largest shipment ever of metallurgical coal to China.
- [By Ben Levisohn]
Should investors be afraid of coal stocks like Arch Coal (ACI), Alpha Natural Resources (ANR) and Peabody Energy (BTU)? Yes, unless they happen to be very long-term investors, says JPMorgan’s John Bridges and team:
- [By Dan Caplinger]
But CSX has responded to the coal crisis in a couple of ways. First, both it and fellow coal-focused railroad Norfolk Southern (NYSE: NSC ) have ramped up their efforts to export coal, as countries such as China and India remain hungry for low-cost-energy alternatives. Peabody Energy (NYSE: BTU ) has a natural advantage in supplying Asia because of its deposits in Australia, allowing it to send coal to India and China more cheaply than its peers, especially those with extensive deposits in the eastern half of the U.S. But even eastern producers have managed to boost their exports considerably, and that's helping the railroads that serve coal companies.
Best Oil Service Companies To Invest In 2014: Capstone Turbine Corporation(CPST)
Capstone Turbine Corporation develops, manufactures, markets, and services turbine generator sets and related parts for use in stationary distributed power generation applications. Its stationary distributed power generation applications include cogeneration combined heat and power (CHP), integrated (CHP), resource recovery, and secure power, as well as combined cooling, heat, and power; and its products are used as battery charging generators for hybrid electric vehicle applications. The company primarily offers microturbine units, subassemblies, and components. It also provides various accessories, including rotary gas compressors with digital controls, heat recovery modules for CHP applications, dual mode controllers that allow automatic transition between grid connect and stand-alone modes, batteries with digital controls for stand-alone/dual-mode operations, power servers for multipacked installations, and protocol converters for Internet access, as well as frames, ex haust ducting, and installation hardware. Further, it remanufactures microturbine engines; and provides after-market parts and services, scheduled and unscheduled maintenance, and factory and on-site training services. The company?s microturbines can be fueled by various sources, including natural gas, propane, sour gas, landfill or digester gas, kerosene, diesel, and biodiesel. It primarily sells its products directly to end users, as well as through distributors in North America, Asia, Australia, Europe, the Russian Federation, and South America. Capstone Turbine Corporation was founded in 1988 and is based in Chatsworth, California.
Advisors' Opinion:- [By Richard Stavros]
I was so scarred by their subsequent crash that when I heard a portfolio manager rhapsodizing about the recent performance of Plug Power Inc (NSDQ: PLUG), Fuelcell Energy Inc (NSDQ: FCEL) and Capstone Turbine Corp (NSDQ: CPST), I could scarcely believe it. These were names that I had not heard in years, names that many investors would like to forget. Indeed, even with the recent run-up in their share prices, the value of these firms today is just a small fraction of what it was back then.
- [By Dan Caplinger]
On Thursday, Capstone Turbine (NASDAQ: CPST ) will release its latest quarterly results. But lately, investors have already anticipated some huge results from the company, having bid the shares up by about 50% in just the past several weeks. Can Capstone deliver on what investors want to see?
No comments:
Post a Comment